These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
36. Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern. Dhamija E; Paul SB; Kedia S Indian J Med Res; 2019 Jan; 149(1):9-17. PubMed ID: 31115369 [TBL] [Abstract][Full Text] [Related]
37. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe. Younossi ZM; Blissett D; Blissett R; Henry L; Stepanova M; Younossi Y; Racila A; Hunt S; Beckerman R Hepatology; 2016 Nov; 64(5):1577-1586. PubMed ID: 27543837 [TBL] [Abstract][Full Text] [Related]
38. Recurrent or de novo nonalcoholic fatty liver disease after liver transplantation: natural history based on liver biopsy analysis. Vallin M; Guillaud O; Boillot O; Hervieu V; Scoazec JY; Dumortier J Liver Transpl; 2014 Sep; 20(9):1064-71. PubMed ID: 24961607 [TBL] [Abstract][Full Text] [Related]
39. Growing challenge of post-liver transplantation non-alcoholic fatty liver disease. Kalogirou MS; Giouleme O World J Transplant; 2022 Sep; 12(9):281-287. PubMed ID: 36187880 [TBL] [Abstract][Full Text] [Related]